Development
Principal Short-Term Income Fund R-5 Class
PSIQX
NASDAQ
| Weiss Ratings | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C- | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Principal Funds | |||
| Manager/Tenure (Years) | Scott J. Peterson (15), Michael Goosay (1), Jeff Callahan (0) | |||
| Website | -- | |||
| Fund Information | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Principal Short-Term Income Fund R-5 Class | |||
| Category | Short-Term Bond | |||
| Sub-Category | US Fixed Income | |||
| Prospectus Objective | Corporate Bond - High Quality | |||
| Inception Date | Jul 12, 2010 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 0.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 3.55% | |||
| Dividend | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | -- | |||
| Asset Allocation | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 1.21% | |||
| Stock | 0.00% | |||
| U.S. Stock | 0.00% | |||
| Non-U.S. Stock | 0.00% | |||
| Bond | 98.79% | |||
| U.S. Bond | 86.83% | |||
| Non-U.S. Bond | 11.96% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.32% | |||
| 30-Day Total Return | 0.38% | |||
| 60-Day Total Return | 1.16% | |||
| 90-Day Total Return | 1.64% | |||
| Year to Date Total Return | 1.64% | |||
| 1-Year Total Return | 5.73% | |||
| 2-Year Total Return | 10.94% | |||
| 3-Year Total Return | 11.20% | |||
| 5-Year Total Return | 11.74% | |||
| Price | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $12.08 | |||
| 1-Month Low NAV | $12.04 | |||
| 1-Month High NAV | $12.08 | |||
| 52-Week Low NAV | $11.77 | |||
| 52-Week Low NAV (Date) | Apr 16, 2024 | |||
| 52-Week High NAV | $12.12 | |||
| 52-Week High Price (Date) | Sep 27, 2024 | |||
| Beta / Standard Deviation | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.98 | |||
| Standard Deviation | 2.41 | |||
| Balance Sheet | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 3.28B | |||
| Operating Ratios | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.62% | |||
| Turnover Ratio | 46.70% | |||
| Performance | PSIQX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 4.22% | |||
| Last Bear Market Total Return | -1.46% | |||